摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(2-Aminoethyl)glycinamide | 84354-31-4

中文名称
——
中文别名
——
英文名称
N-(2-Aminoethyl)glycinamide
英文别名
N-glycylethylenediamine;N-Glycyl-ethylendiamin;2-Amino-N-(2-aminoethyl)acetamide
N-(2-Aminoethyl)glycinamide化学式
CAS
84354-31-4
化学式
C4H11N3O
mdl
——
分子量
117.151
InChiKey
NFSGQYGMPDCEFD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2.3
  • 重原子数:
    8
  • 可旋转键数:
    3
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    81.1
  • 氢给体数:
    3
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Solution thermodynamics of the ferric complexes of new desferrioxamine siderophores obtained by directed fermentation
    摘要:
    Thirteen new desferrioxamine-type siderophores, designated X1-X6, Et1-Et3, Te1-Te3, and P1, were obtained from cultures of Streptomyces olivaceus Tu 2718 by supplementing the production medium with ornithine or 1,4-diaminobutane, 1,6-diaminohexane, bis(2-aminoethyl) ether, S-(2-aminoethyl)cysteine, and N-glycylethylenediamine. The stability constants of the ferric complexes of the trihydroxamate ligands, X1-X4, Et1-Et3, and Te1-Te3, were determined by EDTA competition reactions and are in the range log beta-110 = 29.7-31.8 (beta-110 = [FeL]/([Fe3+] [L3-], 25-degrees-C, 0.1 M KNO3). The stability of the complexes decreases monotonically as the structure of the ligand differs from that of desferrioxamine E (beta-110 = 32.21, 25-degrees-C, 0.1 M KNO3), the main siderophore of S. olivaceus Tu 2718 under natural growth conditions. The dihydroxamic acid desferrioxamine X5 forms two types of ferric complexes, depending on pH. The predominant species above pH 6.4 is a dimer of formulation Fe2L3, Which dissociates into a monomeric cation, FeL+, at lower pH. The stability constants of these two species determined by spectrophotometric titration are log beta-230 = 55.35 and log beta-110 = 19.18 (25-degrees-C, 0.1 M KNO3). The relative effectiveness of the new ferrioxamines as mediators of iron uptake via the hydroxamate ferric ion transport system of Staphylococcus aureus DSM 799 differs widely, however, without correlating with the complex stability.
    DOI:
    10.1021/ja00032a043
  • 作为产物:
    描述:
    benzyl N-[2-oxo-2-[2-(phenylmethoxycarbonylamino)ethylamino]ethyl]carbamate 在 palladium on activated charcoal 氢气 作用下, 以 甲醇 为溶剂, 反应 8.0h, 生成 N-(2-Aminoethyl)glycinamide
    参考文献:
    名称:
    Potential antitumor agents. 44. Synthesis and antitumor activity of new classes of diacridines: importance of linker chain rigidity for DNA binding kinetics and biological activity
    摘要:
    Four classes of diacridines, joined at the 9-position by linker chains of varying length, rigidity, and polarity, were evaluated for DNA-binding properties and antitumor activity. Diacridines linked by flexible chains of varying polarity show relatively fast chromophore exchange kinetics among DNA binding sites but slower dissociation rates, suggesting the potential for considerable "creeping" of the drug along the helix, and are inactive in vivo. The exchange kinetics can be slowed dramatically by inclusion of positive charges in the side chain, but the resulting polycationic drugs are inactive in vivo, possibly due to poor distribution. Diacridines linked by a rigid, polar but neutral dicarbamoylpyrazole chain retain slow exchange kinetics, have a greatly reduced potential "creep rate", and possess good in vitro potency and significant in vivo antileukemic activity.
    DOI:
    10.1021/jm00149a005
点击查看最新优质反应信息

文献信息

  • Noguchi,J. et al., Israel Journal of Chemistry, 1974, vol. 12, p. 87 - 101
    作者:Noguchi,J. et al.
    DOI:——
    日期:——
  • Synthesis and Evaluation of Novel Macrocyclic and Acyclic Ligands as Contrast Enhancement Agents for Magnetic Resonance Imaging
    作者:Hyun-Soon Chong、Kayhan Garmestani、L. Henry Bryant,、Diane E. Milenic、Terrish Overstreet、Noah Birch、Thien Le、Erik D. Brady、Martin W. Brechbiel
    DOI:10.1021/jm051009k
    日期:2006.3.1
    Novel chelates PIP-DTPA, AZEP-DTPA, NETA, NPTA, and PIP-DOTA were synthesized and evaluated as potential magnetic resonance imaging (MRI) contrast enhancement agents. The T-1 and T-2 relaxivities of their corresponding Gd(III) complexes are reported. At clinically relevant field strengths, the relaxivities of the complexes are comparable to that of the clinically used contrast agents Gd(DTPA) and Gd(DOTA). The serum stability of the Gd-153-labeled complexes, Gd(PIP-DTPA), Gd(AZEP-DTPA), Gd(PIP-DOTA), Gd(NETA), and Gd(NPTA), was assessed by measuring the release of Gd-153 from the complexes. Gd-153(NETA), Gd-153(PIP-DTPA), and Gd-153(PIP-DOTA) were found to be stable in human serum for up to 14 days without any measurable loss of radioactivity. Significant release of Gd-153 was observed with the Gd-153(III) radiolabled NPTA. In vivo biodistribution of the Gd-153-labeled complexes was performed to evaluate their in vivo stability. While Gd(AZEP-DTPA) and Gd(NPTA) were found to be unstable in vivo, Gd(NETA), Gd(PIP-DTPA), and Gd(PIP-DOTA) were excreted without dissociation. These results suggest that the Gd(III) complexes of the novel chelates NETA, PIP-DTPA, and PIP-DOTA possess potential as MRI contrast enhancement agents. In particular, the piperidine backboned chelates Gd(PIP-DTPA) and Gd(PIP-DOTA) displayed reduced kidney retention as compared to the nonspecific MRI contrast agent Gd(DOTA) at all time points, although the observed effects were relatively small at 0.5 h postinjection. Incorporation of the lipophilic piperidine ring appears to confer a moderate effect on the liver uptake of these two chelates.
  • FIEDLER, H. -P.;MEIWES, J.;WERNER, I.;KONETSCHNY-RAPP, S.;JUNG, G., J. CHROMATOGR., 513,(1990) C. 255-262
    作者:FIEDLER, H. -P.、MEIWES, J.、WERNER, I.、KONETSCHNY-RAPP, S.、JUNG, G.
    DOI:——
    日期:——
  • DENNY, W. A.;ATWELL, G. J.;BAGULEY, B. C.;WAKALIN, L. P. G., J. MED. CHEM., 1985, 28, N 11, 1568-1574
    作者:DENNY, W. A.、ATWELL, G. J.、BAGULEY, B. C.、WAKALIN, L. P. G.
    DOI:——
    日期:——
  • Design of ligands containing the o-hydroxybenzyl group. Metal-complexing properties of N,N″-bis(2-hydroxybenzyl)diethylenetriamine-N,N′,N″-triacetic acid
    作者:Robert D. Hancock、Ignacy Cukrowski、Ewa Cukrowska、Gladys D. Hosken、Vimal Iccharam、Martin W. Brechbiel、Otto A. Gansow
    DOI:10.1039/dt9940002679
    日期:——
    The ligand N,N''-bis(2-hydroxybenzyl)diethylenetriamine-N,N',N''-triacetic acid (H(5)L) has been synthesised and the protonation constants for L determined by potentiometric methods in 0.5 mol dm(-3) NaNO3, and spectrophotometric methods in 0.5 and 0.1 mol dm(-3) NaCl, all at 25 degrees C. The sites of protonation have been inferred from H-1 NMR studies in D2O. The complex formation constants of Ca-II, Zn-II Cd-II, Cu-II, Pb-II and Bi-III have been determined at 25 degrees C by potentiometric methods in 0.5 mol dm(-3) NaNO3, and spectrophotometric methods in 0.5 mol dm(-3) NaCl. The results show that at biological pH the hydroxybenzyl groups tend to remain protonated, and over most of the pH range protonated complexes dominate, with fully deprotonated complexes occurring only at pH values above 9 or 10. The ligand L is, compared to some of its analogues, effectively a weak complexing agent. This is rationalised in terms of the six-membered chelate rings formed in the complex, which include the hydroxybenzyl group. The six-membered chelate rings destabilize complexes of the larger metal ions with which the octadentate ligand should prefer to co-ordinate.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物